Filling gap in market: VenusP-Valve™ approved by China’s NMPA
- Wednesday, July 13, 2022, 7:14
- Environment
- Add a comment
HANGZHOU, China, July 13, 2022 /PRNewswire/ — On July 11, 2022, VenusP-ValveTM, Venus Medtech’s in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, was approved by China’s National Medical Products Administration (NMPA) for the treatment of severe…
About the Author
adminasapcorp has written 41821 stories on this site.